• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症基因治疗:边缘技术还是前沿技术?

Cancer gene therapy: fringe or cutting edge?

作者信息

McCormick F

机构信息

University of California San Francisco, Cancer Research Institute, 94115, USA.

出版信息

Nat Rev Cancer. 2001 Nov;1(2):130-41. doi: 10.1038/35101008.

DOI:10.1038/35101008
PMID:11905804
Abstract

Direct targeting of cancer cells with gene therapy has the potential to treat cancer on the basis of its molecular characteristics. But although laboratory results have been extremely encouraging, many practical obstacles need to be overcome before gene therapy can fulfil its goals in the clinic. These issues are not trivial, but seem less formidable than the challenge of killing cancers selectively and rationally--a challenge that has been successfully addressed.

摘要

通过基因疗法直接靶向癌细胞有潜力基于其分子特征来治疗癌症。尽管实验室结果非常令人鼓舞,但在基因疗法能够在临床上实现其目标之前,还需要克服许多实际障碍。这些问题并非微不足道,但似乎比选择性且合理地杀死癌症这一挑战的难度要小——而这一挑战已经得到成功解决。

相似文献

1
Cancer gene therapy: fringe or cutting edge?癌症基因治疗:边缘技术还是前沿技术?
Nat Rev Cancer. 2001 Nov;1(2):130-41. doi: 10.1038/35101008.
2
[Gene therapy of tumors, state of the art and prospects].
Pathologica. 2001 Dec;93(6):625-30.
3
Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.腺病毒介导的p53基因治疗:临床前研究概述及潜在临床应用
Curr Opin Mol Ther. 1999 Aug;1(4):500-9.
4
Advances in adenovirus-mediated p53 cancer gene therapy.腺病毒介导的 p53 抑癌基因治疗的研究进展。
Expert Opin Biol Ther. 2013 Nov;13(11):1569-83. doi: 10.1517/14712598.2013.845662.
5
Restoration of wild-type p53 function in human tumors: strategies for efficient cancer therapy.恢复人类肿瘤中野生型p53的功能:高效癌症治疗策略
Adv Cancer Res. 2007;97:321-38. doi: 10.1016/S0065-230X(06)97014-6.
6
Clinical aspects of intratumoral gene therapy.肿瘤内基因治疗的临床方面。
Curr Opin Mol Ther. 1999 Aug;1(4):443-53.
7
Immune enhancement of nitroreductase-induced cytotoxicity: studies using a bicistronic adenovirus vector.硝基还原酶诱导的细胞毒性的免疫增强作用:使用双顺反子腺病毒载体的研究
Int J Cancer. 2003 Mar 10;104(1):104-12. doi: 10.1002/ijc.10916.
8
Gene therapy for ovarian cancer.
Oncology (Williston Park). 2001 Sep;15(9):1197-204, 1207; discussion 1207-8.
9
Introduction to cancer gene therapy.癌症基因治疗导论。
Surg Oncol Clin N Am. 2002 Jul;11(3):497-519, v. doi: 10.1016/s1055-3207(02)00029-7.
10
Adenovirus gene therapy for ovarian cancer.
J Natl Cancer Inst. 2002 May 15;94(10):706-7. doi: 10.1093/jnci/94.10.706.

引用本文的文献

1
Decoding contextual crosstalk: revealing distinct interactions between non-coding RNAs and unfolded protein response in breast cancer.解码上下文串扰:揭示乳腺癌中非编码RNA与未折叠蛋白反应之间的独特相互作用
Cancer Cell Int. 2024 Mar 11;24(1):104. doi: 10.1186/s12935-024-03296-3.
2
Assessing the gene silencing potential of AuNP-based approaches on conventional 2D cell culture versus 3D tumor spheroid.评估基于金纳米颗粒的方法对传统二维细胞培养与三维肿瘤球体的基因沉默潜力。
Front Bioeng Biotechnol. 2024 Feb 12;12:1320729. doi: 10.3389/fbioe.2024.1320729. eCollection 2024.
3
PDGFBB facilitates tumorigenesis and malignancy of lung adenocarcinoma associated with PI3K-AKT/MAPK signaling.
血小板衍生生长因子 BB 促进与 PI3K-AKT/MAPK 信号通路相关的肺腺癌的发生和恶性转化。
Sci Rep. 2024 Feb 20;14(1):4191. doi: 10.1038/s41598-024-54801-7.
4
Current Advances on Nanomaterials Interfering with Lactate Metabolism for Tumor Therapy.纳米材料干扰乳酸代谢在肿瘤治疗中的最新进展。
Adv Sci (Weinh). 2024 Jan;11(3):e2305662. doi: 10.1002/advs.202305662. Epub 2023 Nov 8.
5
Co-Infection and Cancer: Host-Pathogen Interaction between Dendritic Cells and HIV-1, HTLV-1, and Other Oncogenic Viruses.共感染与癌症:树突状细胞与 HIV-1、HTLV-1 和其他致癌病毒之间的宿主-病原体相互作用。
Viruses. 2022 Sep 14;14(9):2037. doi: 10.3390/v14092037.
6
Lipofection with estrone-based luminophores featuring aggregation-induced emission properties.基于具有聚集诱导发光特性的雌酮的发光体的脂质转染。
RSC Adv. 2020 May 27;10(33):19643-19647. doi: 10.1039/d0ra03608k. eCollection 2020 May 20.
7
A Bivalent Supramolecular GCP Ligand Enables Blocking of the Taspase1/Importin α Interaction.双价超分子 GCP 配体可阻断 Taspase1/Importin α 相互作用。
ChemMedChem. 2022 Jan 5;17(1):e202100640. doi: 10.1002/cmdc.202100640. Epub 2021 Oct 19.
8
Improved safety of induced pluripotent stem cell-derived antigen-presenting cell-based cancer immunotherapy.诱导多能干细胞来源的基于抗原呈递细胞的癌症免疫疗法安全性的提高。
Mol Ther Methods Clin Dev. 2021 Mar 5;21:171-179. doi: 10.1016/j.omtm.2021.03.002. eCollection 2021 Jun 11.
9
Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response.产生可诱导细胞毒性T细胞介导的抗肿瘤反应的分泌粒细胞-巨噬细胞集落刺激因子(GM-CSF)的抗原呈递细胞。
Oncoimmunology. 2020 Sep 6;9(1):1814620. doi: 10.1080/2162402X.2020.1814620.
10
Targeted suicide gene therapy for liver cancer based on ribozyme-mediated RNA replacement through post-transcriptional regulation.基于核酶介导的RNA置换通过转录后调控进行的肝癌靶向自杀基因治疗。
Mol Ther Nucleic Acids. 2020 Oct 31;23:154-168. doi: 10.1016/j.omtn.2020.10.036. eCollection 2021 Mar 5.